2225 As much of the evidence base reporting benefits across domains of psychopathology is comprised of persons whose primary diagnosis is either obesity and/or T2DM, the question arises as to whether the psychiatric benefit can be parsimoniously explained as pseudo-specific and a consequence of improvement in anthropometrics and metabolism
Shes finding that a very high percentage of patients would qualify for the medications and want to talk about getting prescriptions
Bizzarri, M., Fuso, A., Dinicola, S., Cucina, A
Beyond weight and blood sugar, many patients report improvements in energy levels, sleep quality, joint pain from reduced weight bearing, and even mental clarity
The TGA requires that medications only be advertised for their approved uses, and patients should be aware that individual responses vary